Advanced Practice Provider-Led Medication for Opioid Use Disorder Programs for Pregnant and Parenting Women.
Dolly Pressley ByrdShelley GalvinMelinda RamageElisabeth JohnsonPublished in: Journal of midwifery & women's health (2022)
This article describes 2 innovative models of advanced practice provider-led medication for opioid use disorder treatment programs offering comprehensive, interprofessional care for pregnant patients and provides implications for broader adaptation of practice. Increasing the number of midwives and nurse practitioners waivered to prescribe buprenorphine and able to connect pregnant patients with opioid use disorder to appropriate community-based resources, treatment, and self-help programs could address alarming substance use trends including overdose deaths and other sequelae associated with the opioid epidemic.
Keyphrases
- primary care
- healthcare
- public health
- end stage renal disease
- pregnant women
- quality improvement
- chronic kidney disease
- ejection fraction
- pain management
- palliative care
- chronic pain
- peritoneal dialysis
- prognostic factors
- type diabetes
- emergency department
- skeletal muscle
- general practice
- insulin resistance
- adverse drug
- combination therapy
- replacement therapy
- pregnancy outcomes